Ascendis Pharma A/S (ASND) Short Interest Ratio & Short Volume → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free ASND Stock Alerts $141.01 +2.57 (+1.86%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ascendis Pharma A/S Short Interest DataCurrent Short Volume3,600,000 sharesPrevious Short Volume3,350,000 sharesChange Vs. Previous Month+7.46%Dollar Volume Sold Short$522.83 millionShort Interest Ratio / Days to Cover10.3Last Record DateApril 15, 2024Outstanding Shares58,220,000 sharesPercentage of Shares Shorted6.18%Today's Trading Volume411,204 sharesAverage Trading Volume364,789 sharesToday's Volume Vs. Average113% Short Selling Ascendis Pharma A/S ? Sign up to receive the latest short interest report for Ascendis Pharma A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatASND Short Interest Over TimeASND Days to Cover Over TimeASND Percentage of Float Shorted Over Time Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! Ascendis Pharma A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,600,000 shares $522.83 million +7.5%N/A10.3 $145.23 3/31/20243,350,000 shares $506.42 million +14.0%N/A8.9 $151.17 3/15/20242,940,000 shares $437.18 million -2.0%N/A7.5 $148.70 2/29/20243,000,000 shares $443.28 million +1.0%N/A5.7 $147.76 2/15/20242,970,000 shares $437.18 million +1.4%N/A5.2 $147.20 1/31/20242,930,000 shares $380.69 million -9.9%N/A5.2 $129.93 Get the Latest News and Ratings for ASND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter. 1/15/20243,250,000 shares $426.50 million -4.7%N/A5.8 $131.23 12/31/20233,410,000 shares $429.49 million -17.8%N/A6 $125.95 12/15/20234,150,000 shares $502.03 million -19.7%N/A7.4 $120.97 11/30/20235,170,000 shares $519.22 million +3.6%N/A10.9 $100.43 11/15/20234,990,000 shares $463.92 million -9.8%N/A13.1 $92.97 10/31/20235,530,000 shares $493.88 million +22.9%N/A15.4 $89.31 10/15/20234,500,000 shares $421.07 million +9.8%N/A13.3 $93.57 9/30/20234,100,000 shares $383.92 million +1.0%N/A14.9 $93.64 9/15/20234,060,000 shares $416.80 million -10.6%N/A15.2 $102.66 8/31/20234,540,000 shares $445.01 million -5.0%N/A18 $98.02 8/15/20234,780,000 shares $442.15 million +6.0%N/A20.2 $92.50 7/31/20234,510,000 shares $406.58 million +6.9%N/A15.8 $90.15 7/15/20234,220,000 shares $365.16 million +3.4%N/A8.5 $86.53 6/30/20234,080,000 shares $364.14 million +0.7%N/A7 $89.25 6/15/20234,050,000 shares $374.46 million +3.1%N/A5 $92.46 5/31/20233,930,000 shares $341.79 million -11.3%N/A4.9 $86.97 5/15/20234,430,000 shares $427.89 million +13.6%N/A5.5 $96.59 4/30/20233,900,000 shares $272.84 million -21.2%N/A5 $69.96 4/15/20234,950,000 shares $401.79 million +51.8%N/A9 $81.17 3/31/20233,260,000 shares $349.54 million -0.3%N/A6.2 $107.22 3/15/20233,270,000 shares $354.86 million -0.3%N/A12.6 $108.52 2/28/20233,280,000 shares $364.38 million -1.2%N/A8.9 $111.09 2/15/20233,320,000 shares $371.84 million +5.1%N/A8.7 $112.00 1/31/20233,160,000 shares $392.09 million +1.6%N/A7.2 $124.08 1/15/20233,110,000 shares $357.74 million -61.3%N/A6.4 $115.03 12/30/20228,030,000 shares $980.70 million -1.8%N/A16.5 $122.13 12/15/20228,180,000 shares $973.50 million -14.6%N/A15.9 $119.01 11/30/20229,580,000 shares $1.18 billion -1.8%N/A18.9 $123.06 11/15/20229,760,000 shares $1.08 billion -4.7%N/A21.1 $110.15 10/31/202210,240,000 shares $1.18 billion +12.9%N/A22.2 $115.00 10/15/20229,070,000 shares $973.48 million -3.8%N/A20 $107.33 9/30/20229,430,000 shares $973.74 million +11.2%N/A20.3 $103.26 9/15/20228,480,000 shares $926.78 million +6.4%N/A19.6 $109.29 8/31/20227,970,000 shares $713.87 million +6.3%N/A19.7 $89.57😱 This phenomenon is smashing regular market gains (Ad)Thanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! ASND Short Interest - Frequently Asked Questions What is Ascendis Pharma A/S's current short interest? Short interest is the volume of Ascendis Pharma A/S shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 3,600,000 shares of ASND short. Learn More on Ascendis Pharma A/S's current short interest. What is a good short interest ratio for Ascendis Pharma A/S? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ASND shares currently have a short interest ratio of 10.0. Learn More on Ascendis Pharma A/S's short interest ratio. Which institutional investors are shorting Ascendis Pharma A/S? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ascendis Pharma A/S: Concourse Financial Group Securities Inc., Simplex Trading LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Ascendis Pharma A/S's short interest increasing or decreasing? Ascendis Pharma A/S saw a increase in short interest in April. As of April 15th, there was short interest totaling 3,600,000 shares, an increase of 7.5% from the previous total of 3,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ascendis Pharma A/S's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ascendis Pharma A/S: Legend Biotech Co. (6.04%), Cerevel Therapeutics Holdings, Inc. (9.10%), Viking Therapeutics, Inc. (10.11%), Roivant Sciences Ltd. (8.18%), Jazz Pharmaceuticals plc (6.14%), Intra-Cellular Therapies, Inc. (3.71%), Elanco Animal Health Incorporated (3.14%), Cytokinetics, Incorporated (13.91%), Ionis Pharmaceuticals, Inc. (7.12%), Catalent, Inc. (3.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Ascendis Pharma A/S stock? Short selling ASND is an investing strategy that aims to generate trading profit from Ascendis Pharma A/S as its price is falling. ASND shares are trading up $2.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ascendis Pharma A/S? A short squeeze for Ascendis Pharma A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ASND, which in turn drives the price of the stock up even further. How often is Ascendis Pharma A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASND, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LEGN Short Interest CERE Short Interest VKTX Short Interest ROIV Short Interest JAZZ Short Interest ITCI Short Interest ELAN Short Interest CYTK Short Interest IONS Short Interest CTLT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ASND) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New Device is About to Shock the WorldInvestorPlaceThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Nvidia. This is the future of AIPorter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing